药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Econazole
Ecromeximab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Ecromeximab.
Econazole
Abituzumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Abituzumab.
Econazole
Sifalimumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Sifalimumab.
Econazole
Demcizumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Demcizumab.
Econazole
Carlumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Carlumab.
Econazole
Intetumumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Intetumumab.
Econazole
Ibalizumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Ibalizumab.
Econazole
Lumretuzumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Lumretuzumab.
Econazole
Tovetumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Tovetumab.
Econazole
Dacetuzumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Dacetuzumab.
Econazole
Bimagrumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Bimagrumab.
Econazole
Blosozumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Blosozumab.
Econazole
Mavrilimumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Mavrilimumab.
Econazole
Plozalizumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Plozalizumab.
Econazole
Mogamulizumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Mogamulizumab.
Econazole
Bococizumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Bococizumab.
Econazole
Indusatumab vedotin
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Indusatumab vedotin.
Econazole
Fresolimumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Fresolimumab.
Econazole
Dusigitumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Dusigitumab.
Econazole
Fezakinumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Fezakinumab.